Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart.
Bartnik M, Rydén L, Malmberg K, Ohrvik J, Pyörälä K, Standl E, Ferrari R, Simoons M, Soler-Soler J; Euro Heart Survey Investigators. Bartnik M, et al. Among authors: simoons m. Heart. 2007 Jan;93(1):72-7. doi: 10.1136/hrt.2005.086975. Epub 2006 Aug 11. Heart. 2007. PMID: 16905628 Free PMC article.
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Lenzen M, Ryden L, Ohrvik J, Bartnik M, Malmberg K, Scholte Op Reimer W, Simoons ML; Euro Heart Survey Investigators. Lenzen M, et al. Among authors: simoons ml. Eur Heart J. 2006 Dec;27(24):2969-74. doi: 10.1093/eurheartj/ehl363. Epub 2006 Nov 7. Eur Heart J. 2006. PMID: 17090612
The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation.
Lenzen MJ, Scholte op Reimer WJ, Pedersen SS, Boersma E, Maier W, Widimsky P, Simoons ML, Mercado NF, Wijns W; Euro Heart Survey on Coronary Revascularization. Lenzen MJ, et al. Among authors: simoons ml. Heart. 2007 Mar;93(3):339-44. doi: 10.1136/hrt.2005.086868. Epub 2006 Sep 15. Heart. 2007. PMID: 16980515 Free PMC article.
Perindopril and β-blocker for the prevention of cardiac events and mortality in stable coronary artery disease patients: A EUropean trial on Reduction Of cardiac events with Perindopril in stable coronary Artery disease (EUROPA) subanalysis.
Bertrand ME, Ferrari R, Remme WJ, Simoons ML, Fox KM. Bertrand ME, et al. Among authors: simoons ml. Am Heart J. 2015 Dec;170(6):1092-8. doi: 10.1016/j.ahj.2015.08.018. Epub 2015 Aug 28. Am Heart J. 2015. PMID: 26678630 Clinical Trial.
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery disease.
Battes L, Barendse R, Steyerberg EW, Simoons ML, Deckers JW, Nieboer D, Bertrand M, Ferrari R, Remme WJ, Fox K, Takkenberg JJ, Boersma E, Kardys I. Battes L, et al. Among authors: simoons ml. Am J Cardiol. 2013 Jul 1;112(1):27-33. doi: 10.1016/j.amjcard.2013.02.049. Epub 2013 Apr 1. Am J Cardiol. 2013. PMID: 23558041 Clinical Trial.
601 results